
Curaleaf — Investor Relations & Filings
Curaleaf is a vertically integrated international provider of cannabis consumer products. The company specializes in the cultivation, processing, and distribution of medical and wellness cannabis across North America and expanding international markets, particularly in Europe. Curaleaf employs a research-led approach to drive evidence-based innovation and advance patient care. Its operations focus on enhancing lives by offering a diverse portfolio of cannabis formats, including flower and tinctures, tailored to individual consumer needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release (section 4.8 of NI 62-104) – English.pdf | 2026-04-17 | English | |
| News release (section 4.8 of NI 62-104) – English.pdf | 2026-04-17 | English | |
| News release - English.pdf | 2026-03-31 | English | |
| News release - English.pdf | 2026-02-16 | English | |
| News release - English.pdf | 2026-02-16 | English | |
| News release - English.pdf | 2026-02-16 | English |
Browse filings by year
7 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Centessa Pharmaceuticals plc
Clinical-stage pharmaceutical company developing medicines …
|
CNTA | GB | Manufacturing |
|
Century Therapeutics, Inc.
Develops iPSC-derived allogeneic cell therapies for cancer …
|
IPSC | US | Manufacturing |
|
Cereno Scientific AB
Clinical-stage biotech developing drugs for rare cardiovasc…
|
CRNO | SE | Manufacturing |
|
CERO THERAPEUTICS HOLDINGS, INC.
Immunotherapy company developing engineered T cell therapeu…
|
CERO | US | Manufacturing |
|
CERUS CORP
Develops pathogen inactivation technology to reduce transfu…
|
CERS | US | Manufacturing |
|
Cessatech A/S
A biotech company developing medicines for children's acute…
|
CESSA | DK | Manufacturing |
|
CF PharmTech
Develops and manufactures inhalation drugs and delivery sys…
|
2652 | CN | Manufacturing |
|
CF PharmTech, Inc.
Specialty pharmaceutical company developing complex inhalat…
|
2652 | HK | Manufacturing |
|
CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomic…
|
083790 | KR | Manufacturing |
|
CG Oncology, Inc.
Develops bladder-sparing oncolytic immunotherapies for urol…
|
CGON | US | Manufacturing |
Curaleaf via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47285/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47285 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47285 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47285 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47285}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Curaleaf (id: 47285)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.